Bruker Takes $10M in Stimulus Orders

Aug 28, 2009

NEW YORK (GenomeWeb News) – Bruker said this week that it has taken in $10 million in orders due to stimulus programs in the US, Japan, and Europe.

The firm disclosed in a filing with the US Securities and Exchange Commission that by the end of August it had booked $10 million in orders due the various stimulus programs, with more than $3 million coming from Japan. It said that it had booked five system orders from that country.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in PNAS

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

Leaving It All Over Town

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

Balance of Research and Privacy

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

What We'd Do With the Money

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

Featured White Papers

Reverse Phase Protein Arrays for Cell Signaling: Using the InnoScan 710-IR scanner improves sensitivity and dynamic range.

Infrared detection decreases nitrocellulose autofluorescence and improves RPPA assays signal‐to‐noise ratio over visible wavelength detection

Mar

05

Featured Webinar

Integrating Metabolomic and Proteomic Profiles for 'Less Impersonal' Medicine

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.

Main menu